首页> 美国卫生研究院文献>International Journal of Clinical and Experimental Pathology >HMGB1 enhances smooth muscle cell proliferation and migration in pulmonary artery remodeling
【2h】

HMGB1 enhances smooth muscle cell proliferation and migration in pulmonary artery remodeling

机译:HMGB1在肺动脉重构中增强平滑肌细胞增殖和迁移

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

HMGB1 is a necessary and critical mediator of acute lung injury and can act as a chemoattractant and anti-apoptosis factor in injury or repair in diseases. In this study we sought to determine whether HMGB1 is involved in the remodeling of pulmonary artery and investigate the mechanism. A rat model of pulmonary artery remodeling was successful induced with LPS infusion and the increasing of pulmonary arteries media was obviously inhibited in rats treated with thrice inject of HMGB1 neutralizing antibody. The percent of areas of tunica media to total artery wall was (0.53±0.15), (0.81±0.10) and (0.59±0.11) in control, LPS and antibody group respectively (p<0.05). Meanwhile, treatment with HMGB1 neutralizing antibody not only decreased the level of HMGB1 mRNA and protein significantly, but inhibited the expression of PCAN and Bcl-2 as well. On the contrary, Bax, a gen which represented the apoptosis, revealed an absolutely reversed trend to Bcl-2 in pulmonary arteries. Experiments in vitro showed that HMGB1 could stimulate the proliferation of hPASMC in MTT test and increase the number of migrated cells in a concentration-dependent manner in chemotaxis assay using modified Boyden chambers. In conclusion, data from this study support the concept that HMGB1 is involved in the remodeling of pulmonary artery by enhancing proliferation and migration of smooth muscle cell. Inhibiting HMGB1 may be a new target to deal with the remodeling of pulmonary artery.
机译:HMGB1是急性肺损伤的必要和关键介质,可在疾病的损伤或修复中充当趋化因子和抗凋亡因子。在这项研究中,我们试图确定HMGB1是否参与肺动脉的重塑并研究其机制。 LPS输注成功建立了大鼠肺动脉重塑模型,三次注射HMGB1中和抗体处理的大鼠肺动脉介质的增加受到明显抑制。对照组,LPS组和抗体组的中膜相对于总动脉壁的面积百分比分别为(0.53±0.15),(0.81±0.10)和(0.59±0.11)(p <0.05)。同时,用HMGB1中和抗体处理不仅显着降低了HMGB1的mRNA和蛋白水平,而且还抑制了PCAN和Bcl-2的表达。相反,代表细胞凋亡的基因Bax在肺动脉中显示出与Bcl-2绝对相反的趋势。体外实验表明,在改良的Boyden室进行的趋化性试验中,HMGB1在MTT试验中可以刺激hPASMC的增殖并以浓度依赖的方式增加迁移细胞的数量。总之,这项研究的数据支持HMGB1通过增强平滑肌细胞的增殖和迁移而参与肺动脉重塑的概念。抑制HMGB1可能是应对肺动脉重构的新目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号